Bafna Pharma.

{
  "main_header": {
    "sid": 852453,
    "name": "Bafna Pharma.",
    "stock_name": "Bafna Pharma.",
    "full_name": "Bafna Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/bafna-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "114.00",
    "chg": -4.55,
    "chgp": "-3.84%",
    "dir": -1,
    "prev_price": "118.55",
    "mcapval": "279.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532989,
    "symbol": "BAFNAPH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE878I01022",
    "curr_date": "Mar 27",
    "curr_time": "",
    "bse_nse_vol": "18.9 k",
    "exc_status": "Active",
    "traded_date": "Mar 27, 2026",
    "traded_date_str": "2026 03 27",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bafna-pharma-852453-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3919408",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_stocks_hitting_lower_circuit_3919408.png",
        "date": "2026-03-27 12:00:11",
        "description": "At Rs 111.84, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5% on 27 Mar 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-strong-sell-3919015",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_mojoScore_3919015.png",
        "date": "2026-03-27 10:10:03",
        "description": "Bafna Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3915771",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_stocks_hitting_lower_circuit_3915771.png",
        "date": "2026-03-25 10:00:12",
        "description": "At Rs 107.99, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5% on 25 Mar 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3910560",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_stocks_hitting_lower_circuit_3910560.png",
        "date": "2026-03-24 13:00:07",
        "description": "At Rs 113.67, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 24 Mar 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 4.99% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3906868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_stocks_hitting_lower_circuit_3906868.png",
        "date": "2026-03-23 10:00:21",
        "description": "At Rs 119.65, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 4.99% on 23 Mar 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock."
      },
      {
        "title": "Bafna Pharmaceuticals Gains 27.46%: 6 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-gains-2746-6-key-factors-driving-the-surge-3905348",
        "imagepath": "",
        "date": "2026-03-21 15:04:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Downgrade to Strong Sell; stock hits upper circuit at Rs.104.11 (+4.99%)</p>\n                    <p><strong>17 Mar:</strong> Upper circuit hit again at Rs.109.31 (+4.99%) with rising delivery volumes</p>\n                    <p><strong>18 Mar:</strong> Third consecutive upper circuit close at Rs.114.77 (+4.99%) amid volatile trading</p>\n                    <p><strong>19 Mar:</strong> Fourth upper circuit close at Rs.119.15 (+4.89%) with increased investor participation</p>\n                    <p><strong>20 Mar:</strong> Fifth consecutive upper circuit close at Rs.125.10 (+4.99%) with strong delivery volume surge</p>\n                </div>\n\n                <div clas..."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3903008",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_stocks_hitting_upper_circuit_3903008.png",
        "date": "2026-03-20 11:00:08",
        "description": "At Rs 126.52, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5% on 19 Mar 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-momentum-3900059",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_stocks_hitting_upper_circuit_3900059.png",
        "date": "2026-03-19 10:00:13",
        "description": "Bafna Pharmaceuticals Ltd (Stock ID: 852453) surged to its upper circuit limit on 19 Mar 2026, closing at ₹120.5, marking a maximum daily gain of 4.99%. This sharp rally was driven by robust buying interest, with the stock outperforming its sector and broader market indices despite a subdued market environment."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3898425",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BafnaPharmaceut_stocks_hitting_upper_circuit_3898425.png",
        "date": "2026-03-18 10:00:17",
        "description": "Bafna Pharmaceuticals Ltd surged to hit its upper circuit limit on 18 Mar 2026, reflecting robust buying interest and a maximum daily gain of 4.99%. The micro-cap pharmaceutical stock outperformed its sector and broader market indices, signalling renewed investor enthusiasm despite its Strong Sell mojo grade."
      }
    ],
    "total": 291,
    "sid": "852453",
    "stock_news_url": "https://www.marketsmojo.com/news/bafna-pharmaceuticals-852453"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome For Board Meeting Held On 27/03/2026",
      "datetime": "27-Mar-2026",
      "details": "The Board of Directors of the Company in the Meeting held on March 27 2026 has inter-alia considered and approved: (i) The appointment of M/s. K. S. Rao & Co. Chartered Accountants Chennai as the Internal Auditor of the Company for the Financial Year 2026-2027; (ii) The appointment of M/s. N. Sivashankaran & Co. Cost Accountants Chennai as the Cost Auditor of the Company for the Financial Year 2026-2027.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2026",
      "details": "Intimation for Closure of Trading Window.",
      "source": "BSE"
    },
    {
      "caption": "Clarification On Price Movement",
      "datetime": "24-Mar-2026",
      "details": "We hereby submit our response to the clarification sought by the Stock Exchange regarding the movement in the share price of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13",
          "dt": "2013-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight

2026-03-27 12:00:11

At Rs 111.84, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5% on 27 Mar 2026, with unfilled sell orders and a frozen price.

Read full news article

Bafna Pharmaceuticals Ltd is Rated Strong Sell

2026-03-27 10:10:03

Bafna Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight

2026-03-25 10:00:12

At Rs 107.99, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5% on 25 Mar 2026, with unfilled sell orders and a frozen price.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

2026-03-24 13:00:07

At Rs 113.67, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 24 Mar 2026, with unfilled sell orders and a frozen price.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Lower Circuit With 4.99% Loss — Sellers Queue, No Buyers in Sight

2026-03-23 10:00:21

At Rs 119.65, sellers were still queuing — but there were no buyers willing to take the other side. Bafna Pharmaceuticals Ltd locked at its lower circuit of 4.99% on 23 Mar 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock.

Read full news article

Bafna Pharmaceuticals Gains 27.46%: 6 Key Factors Driving the Surge

2026-03-21 15:04:33

Key Events This Week

16 Mar: Downgrade to Strong Sell; stock hits upper circuit at Rs.104.11 (+4.99%)

17 Mar: Upper circuit hit again at Rs.109.31 (+4.99%) with rising delivery volumes

18 Mar: Third consecutive upper circuit close at Rs.114.77 (+4.99%) amid volatile trading

19 Mar: Fourth upper circuit close at Rs.119.15 (+4.89%) with increased investor participation

20 Mar: Fifth consecutive upper circuit close at Rs.125.10 (+4.99%) with strong delivery volume surge

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-03-20 11:00:08

At Rs 126.52, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5% on 19 Mar 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Bafna Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Momentum

2026-03-19 10:00:13

Bafna Pharmaceuticals Ltd (Stock ID: 852453) surged to its upper circuit limit on 19 Mar 2026, closing at ₹120.5, marking a maximum daily gain of 4.99%. This sharp rally was driven by robust buying interest, with the stock outperforming its sector and broader market indices despite a subdued market environment.

Read full news article

Bafna Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-03-18 10:00:17

Bafna Pharmaceuticals Ltd surged to hit its upper circuit limit on 18 Mar 2026, reflecting robust buying interest and a maximum daily gain of 4.99%. The micro-cap pharmaceutical stock outperformed its sector and broader market indices, signalling renewed investor enthusiasm despite its Strong Sell mojo grade.

Read full news article

View All News